Cell Biology Unit, Institute de Genetique Humain, CNRS-UPR1142, Montpellier, France.
PLoS One. 2010 Jul 26;5(7):e11798. doi: 10.1371/journal.pone.0011798.
The dual specificity phosphatase cdc25C was the first human cdc25 family member found to be essential in the activation of cdk1/cyclin B1 that takes place at the entry into mitosis. Human cdc25C is phosphorylated on Proline-dependent SP and TP sites when it becomes active at mitosis and the prevalent model is that this phosphorylation/activation of cdc25C would be part of an amplification loop with cdk1/cyclin B1.
METHODOLOGY/PRINCIPAL FINDINGS: Using highly specific antibodies directed against cdc25C phospho-epitopes, pT67 and pT130, we show here that these two phospho-forms of cdc25C represent distinct pools with differential localization during human mitosis. Phosphorylation on T67 occurs from prophase and the cdc25C-pT67 phospho-isoform closely localizes with condensed chromosomes throughout mitosis. The phospho-T130 form of cdc25C arises in late G2 and associates predominantly with centrosomes from prophase to anaphase B where it colocalizes with Plk1. As shown by immunoprecipitation of each isoform, these two phospho-forms are not simultaneously phosphorylated on the other mitotic TP sites or associated with one another. Phospho-T67 cdc25C co-precipitates with MPM2-reactive proteins while pT130-cdc25C is associated with Plk1. Interaction and colocalization of phosphoT130-cdc25C with Plk1 demonstrate in living cells, that the sequence around pT130 acts as a true Polo Box Domain (PBD) binding site as previously identified from in vitro peptide screening studies. Overexpression of non-phosphorylatable alanine mutant forms for each isoform, but not wild type cdc25C, strongly impairs mitotic progression showing the functional requirement for each site-specific phosphorylation of cdc25C at mitosis.
CONCLUSIONS/SIGNIFICANCE: These results show for the first time that in human mitosis, distinct phospho-isoforms of cdc25C exist with different localizations and interacting partners, thus implying that the long-standing model of a cdc25C/cdk1 multi-site auto amplification loop is implausible.
双特异性磷酸酶 cdc25C 是第一个被发现对有丝分裂进入时 CDK1/细胞周期蛋白 B1 的激活至关重要的人 cdc25 家族成员。人 cdc25C 在丝氨酸/苏氨酸依赖的 SP 和 TP 位点被磷酸化,当它在有丝分裂中变得活跃时,流行的模型是这种 cdc25C 的磷酸化/激活将是与 CDK1/细胞周期蛋白 B1 的扩增环的一部分。
方法/主要发现:使用针对 cdc25C 磷酸化表位 pT67 和 pT130 的高度特异性抗体,我们在这里表明,这两种 cdc25C 的磷酸化形式代表了在人类有丝分裂过程中具有不同定位的不同池。T67 的磷酸化从前期开始,cdc25C-pT67 磷酸化同工型在整个有丝分裂过程中与浓缩的染色体紧密定位。cdc25C 的磷酸化-T130 形式出现在晚期 G2 期,并主要与从前期到后期 B 的中心体相关,在那里它与 Plk1 共定位。如通过免疫沉淀每种同工型所示,这两种磷酸化形式不会同时在其他有丝分裂 TP 位点上被磷酸化或彼此相关联。磷酸化-T67 cdc25C 与 MPM2 反应蛋白共沉淀,而 pT130-cdc25C 与 Plk1 相关联。磷酸化-T130-cdc25C 与 Plk1 的相互作用和共定位在活细胞中表明,如以前通过体外肽筛选研究所确定的,pT130 周围的序列充当真正的 Polo 盒结构域 (PBD) 结合位点。表达每个同工型的非磷酸化丙氨酸突变形式,但不是野生型 cdc25C,强烈地损害有丝分裂进程,表明 cdc25C 在有丝分裂时的每个位点特异性磷酸化的功能要求。
结论/意义:这些结果首次表明,在人类有丝分裂中,存在具有不同定位和相互作用伙伴的不同磷酸化同工型,因此暗示长期存在的 cdc25C/CDK1 多位点自动扩增环模型是不可信的。